Royalty Pharma Dividend
Dividend criteria checks 3/6
Royalty Pharma is a dividend paying company with a current yield of 3.12% that is well covered by earnings.
Key information
3.1%
Dividend yield
45%
Payout ratio
Industry average yield | 2.2% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | US$1.77 |
Dividend yield forecast in 3Y | 3.8% |
Recent dividend updates
Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21
Apr 28Royalty Pharma (NASDAQ:RPRX) Will Pay A Larger Dividend Than Last Year At $0.21
Jan 31Recent updates
Royalty Pharma plc (NASDAQ:RPRX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 12Royalty Pharma: Solid Start Of The Year, Buy Confirmed
May 11Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21
Apr 28Unpleasant Surprises Could Be In Store For Royalty Pharma plc's (NASDAQ:RPRX) Shares
Apr 25Is Royalty Pharma (NASDAQ:RPRX) Using Too Much Debt?
Apr 04Royalty Pharma's (NASDAQ:RPRX) Earnings Are Weaker Than They Seem
Feb 22Royalty Pharma: Solid Operational Performance
Feb 19Royalty Pharma (NASDAQ:RPRX) Will Pay A Larger Dividend Than Last Year At $0.21
Jan 31Royalty Pharma: One Of The Best Names In Pharmaceuticals
Jan 22Royalty Pharma plc's (NASDAQ:RPRX) Share Price Matching Investor Opinion
Dec 26Royalty Pharma's (NASDAQ:RPRX) Upcoming Dividend Will Be Larger Than Last Year's
May 12Royalty Pharma (NASDAQ:RPRX) Is Increasing Its Dividend To $0.20
Apr 20Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be Increased To $0.20
Jan 16Royalty Pharma to co-fund development of schizophrenia drug with Merck
Oct 12Royalty Pharma: Strategic Royalty Interest Acquisition To Drive Significant Growth
Aug 18Royalty Pharma declares $0.19 dividend
Jul 15Royalty Pharma: Unique Diversification, Bear Market Performer
May 26The Price Is Right For Royalty Pharma plc (NASDAQ:RPRX)
Apr 25Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, RPRX has been paying a dividend for less than 10 years.
Growing Dividend: RPRX's dividend payments have increased, but the company has only paid a dividend for 4 years.
Dividend Yield vs Market
Royalty Pharma Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (RPRX) | 3.1% |
Market Bottom 25% (US) | 1.6% |
Market Top 25% (US) | 4.8% |
Industry Average (Pharmaceuticals) | 2.2% |
Analyst forecast in 3 Years (RPRX) | 3.8% |
Notable Dividend: RPRX's dividend (3.12%) is higher than the bottom 25% of dividend payers in the US market (1.55%).
High Dividend: RPRX's dividend (3.12%) is low compared to the top 25% of dividend payers in the US market (4.81%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (45.5%), RPRX's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (49.3%), RPRX's dividend payments are well covered by cash flows.